HLSE:PIHLIS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Pihlajalinna Oyj provides social and healthcare services for private persons, businesses, insurance companies, municipalities, and hospital districts in Finland. More Details


Snowflake Analysis

Undervalued with reasonable growth potential.

Share Price & News

How has Pihlajalinna Oyj's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: PIHLIS is less volatile than 75% of Finnish stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: PIHLIS's weekly volatility (3%) has been stable over the past year.


Market Performance


7 Day Return

4.2%

PIHLIS

-0.03%

FI Healthcare

1.4%

FI Market


1 Year Return

-34.7%

PIHLIS

-4.5%

FI Healthcare

9.7%

FI Market

Return vs Industry: PIHLIS underperformed the Finnish Healthcare industry which returned -4.7% over the past year.

Return vs Market: PIHLIS underperformed the Finnish Market which returned 8.6% over the past year.


Shareholder returns

PIHLISIndustryMarket
7 Day4.2%-0.03%1.4%
30 Day11.1%2.9%6.7%
90 Day5.5%8.1%12.0%
1 Year-34.7%-34.7%-2.9%-4.5%19.0%9.7%
3 Year-30.9%-32.4%-12.9%-17.1%37.1%13.1%
5 Year-40.0%-41.9%3.3%-3.7%75.9%37.1%

Long-Term Price Volatility Vs. Market

How volatile is Pihlajalinna Oyj's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Pihlajalinna Oyj undervalued compared to its fair value and its price relative to the market?

48.5%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: PIHLIS (€10) is trading below our estimate of fair value (€19.37)

Significantly Below Fair Value: PIHLIS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: PIHLIS is good value based on its PE Ratio (25.2x) compared to the XE Healthcare industry average (26.7x).

PE vs Market: PIHLIS is good value based on its PE Ratio (25.2x) compared to the Finnish market (26.4x).


Price to Earnings Growth Ratio

PEG Ratio: PIHLIS is good value based on its PEG Ratio (0.8x)


Price to Book Ratio

PB vs Industry: PIHLIS is overvalued based on its PB Ratio (2.1x) compared to the XE Healthcare industry average (2x).


Next Steps

Future Growth

How is Pihlajalinna Oyj forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

30.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: PIHLIS's forecast earnings growth (30.3% per year) is above the savings rate (0.3%).

Earnings vs Market: PIHLIS's earnings (30.3% per year) are forecast to grow faster than the Finnish market (15.9% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: PIHLIS's revenue (4.4% per year) is forecast to grow faster than the Finnish market (4.2% per year).

High Growth Revenue: PIHLIS's revenue (4.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: PIHLIS's Return on Equity is forecast to be low in 3 years time (13.6%).


Next Steps

Past Performance

How has Pihlajalinna Oyj performed over the past 5 years?

2.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: PIHLIS has a large one-off loss of €3.1M impacting its September 30 2020 financial results.

Growing Profit Margin: PIHLIS's current net profit margins (1.8%) are higher than last year (0.4%).


Past Earnings Growth Analysis

Earnings Trend: PIHLIS's earnings have grown by 2.3% per year over the past 5 years.

Accelerating Growth: PIHLIS's earnings growth over the past year (292%) exceeds its 5-year average (2.3% per year).

Earnings vs Industry: PIHLIS earnings growth over the past year (292%) exceeded the Healthcare industry -0.3%.


Return on Equity

High ROE: PIHLIS's Return on Equity (7.2%) is considered low.


Next Steps

Financial Health

How is Pihlajalinna Oyj's financial position?


Financial Position Analysis

Short Term Liabilities: PIHLIS's short term assets (€76.0M) do not cover its short term liabilities (€121.0M).

Long Term Liabilities: PIHLIS's short term assets (€76.0M) do not cover its long term liabilities (€197.4M).


Debt to Equity History and Analysis

Debt Level: PIHLIS's debt to equity ratio (86.8%) is considered high.

Reducing Debt: PIHLIS's debt to equity ratio has increased from 43% to 86.8% over the past 5 years.

Debt Coverage: PIHLIS's debt is well covered by operating cash flow (49.8%).

Interest Coverage: PIHLIS's interest payments on its debt are well covered by EBIT (4.5x coverage).


Balance Sheet


Next Steps

Dividend

What is Pihlajalinna Oyj current dividend yield, its reliability and sustainability?

1.93%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate PIHLIS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PIHLIS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PIHLIS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PIHLIS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: PIHLIS is not paying a notable dividend for the Finnish market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of PIHLIS's dividend in 3 years as they are not forecast to pay a notable one for the Finnish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

Joni Raimo Aaltonen (50 yo)

3.08yrs

Tenure

€284,725

Compensation

Mr. Joni Raimo Mikael Aaltonen has been Chief Executive Officer of Pihlajalinna Oyj since December 11, 2017 and has been its Chairman of the Management Team since August 15, 2019. He was Director of VMP Oy...


CEO Compensation Analysis

Compensation vs Market: Joni Raimo's total compensation ($USD345.79K) is about average for companies of similar size in the Finnish market ($USD462.74K).

Compensation vs Earnings: Joni Raimo's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Joni Raimo Aaltonen
CEO & Chairman of the Management Team3.08yrs€284.73k0.36%
€ 818.4k
Tarja Kristiina Rantala
Chief Financial Officer1.42yrsno data0.046%
€ 104.4k
Teija Kulmala
Group COO and CEO of Jämsän Terveys Oy & Jokilaakson Terveys Oy1.42yrsno data0.027%
€ 59.9k
Sanna Määttänen
Chief Business Development Officer & Chief Information Officerno datano data0.052%
€ 116.9k
Taina Erkkilä
Head of Communications & IR2yrsno datano data
Marko Savolainen
Chief Legal Officer2.08yrsno data0.018%
€ 40.0k
Juha Halttunen
Sales Director0.58yrno datano data
Elina Heliö
Chief People & Culture Officer1.67yrsno data0.0045%
€ 10.1k

1.7yrs

Average Tenure

51yo

Average Age

Experienced Management: PIHLIS's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Seija Turunen
Independent Director5yrs€34.50kno data
Leena Niemistö
Independent Vice-Chairman1.75yrs€42.50k3.12%
€ 7.0m
Hannu Juvonen
Independent Director1.75yrs€26.50kno data
Matti Jaakola
Independent Director1.75yrs€26.50kno data
Mikko Wirén
Chairman of the Board4.42yrs€260.00kno data
Kati Sulin
Independent Director2.75yrs€31.50kno data
Mika Manninen
Independent Director1.75yrs€26.50kno data

1.8yrs

Average Tenure

57yo

Average Age

Experienced Board: PIHLIS's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Pihlajalinna Oyj's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Pihlajalinna Oyj
  • Ticker: PIHLIS
  • Exchange: HLSE
  • Founded: 2001
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: €225.578m
  • Shares outstanding: 22.56m
  • Website: https://www.pihlajalinna.fi

Number of Employees


Location

  • Pihlajalinna Oyj
  • KehrAesaari B
  • Tampere
  • Pirkanmaa
  • 33200
  • Finland

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PIHLISHLSE (OMX Nordic Exchange Helsinki)YesShare CapitalFIEURJun 2015
PIHLIhBATS-CHIXE (BATS 'Chi-X Europe')YesShare CapitalGBEURJun 2015
0R8HLSE (London Stock Exchange)YesShare CapitalGBEURJun 2015
38PDB (Deutsche Boerse AG)YesShare CapitalDEEURJun 2015
PIHL.FOTCPK (Pink Sheets LLC)YesShare CapitalUSUSDJun 2015

Biography

Pihlajalinna Oyj provides social and healthcare services for private persons, businesses, insurance companies, municipalities, and hospital districts in Finland. It offers emergency and on-call, occupation...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/01/22 19:13
End of Day Share Price2021/01/22 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.